Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07209358 · ClinicalTrials.gov registry record · NA
EDX110 Randomized Control Trial for Treatment of DFUs
A NA study of Diabetic Foot Ulcer and Wound Heal, sponsored by ConvaTec.
- Recruiting
- Registry status
- NA
- Development phase
- 298
- Enrollment target
- 4
- Study locations
NCT07209358: Recruiting NA study of Diabetic Foot Ulcer and Wound Heal, sponsored by ConvaTec.
NCT07209358 is a NA study of Diabetic Foot Ulcer and Wound Heal that is actively recruiting participants, run by ConvaTec. The registered enrollment target is 298 participants, above the 251-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (19% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07209358, a NA study of Diabetic Foot Ulcer and Wound Heal, is actively recruiting participants, sponsored by ConvaTec.
- RECRUITING
- Registry status
- NA
- Development phase
- 298 participants
- Enrollment target
- 4
- Study locations
Study Summary
Prospective, multi-centered, observer blinded, pre-market study, 1:1 randomized control trial, to determine if addition of EDX110 dressing system to standard of care leads to an improvement in diabetic foot ulcers healing compared to just using standard of care.
Primary Outcome
Incidence of complete wound closure at 16 weeks in participants with DFU who are receiving standard of care (SOC) versus participants receiving EDX110 and SOC. Wound closure is defined as 100% reepithelialization of the wound without drainage.
Conditions Studied
Interventions
- DEVICE EDX110
Study Locations (4)
California
- Clemente Clinical Research - Santa Ana
- ILD Research Center - Vista
Arizona
- Axentra Bio - Phoenix
Texas
- Futuro Clinical Trials - McAllen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2025-10-30 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07209358 shows while recruiting
NCT07209358 is an interventional study that assigns participants to a tested intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, above the 251-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (19% higher).
The record links to 2 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which EDX110 is the first listed.
NCT07209358 reports a single indexed study location in California, Arizona, Texas.
Frequently Asked Questions
What is clinical trial NCT07209358 about?
NCT07209358 is a clinical study titled "EDX110 Randomized Control Trial for Treatment of DFUs". Prospective, multi-centered, observer blinded, pre-market study, 1:1 randomized control trial, to determine if addition of EDX110 dressing system to standard of care leads to an improvement in diabetic foot ulcers healing compared to just using standard of care.
What is the current status of trial NCT07209358?
This trial is currently recruiting. It is a NA study. The enrollment target is 298 participants. The study started on 2025-10-30. Estimated completion is 2026-12-31.
What conditions does trial NCT07209358 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Wound Heal.
What interventions are being tested in trial NCT07209358?
The interventions under investigation include: EDX110 (DEVICE).
Who is sponsoring clinical trial NCT07209358?
This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07209358 being conducted?
This trial has 4 study locations across Arizona, California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07209358's enrollment target sits among peer trials
298 11th of 67 higher than 57 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
- NCT06754215 · 298 participants · NA
Smoking Cessation Intervention Development for Homeless Youth
- NCT06780111 · 298 participants · Phase 1
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI